We serve patients across Dallas, Fort Worth, Plano, Colleyville, Argyle, Waxahachie, The Woodlands, Austin, and via telehealth across Texas
I believe it relates to health of vagal afferent signaling and GLP-1 resistance
Estrogen decline reshapes appetite signaling, shifts fat storage toward the middle, and changes how side effects feel, and it does all of this unevenly, sometimes month to month
These findings support the continued development of retatrutide as a potential treatment option for type 2 diabetes, with ongoing phase 3 trials set to further evaluate its efficacy and safety
These receptors are involved in appetite regulation, insulin response, energy expenditure, and fat metabolism
Retatrutide is a triple receptor agonist targeting GLP-1, GIP, and glucagon receptors a mechanism distinct from semaglutide and tirzepatide